BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24176625)

  • 1. Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.
    Teipel S; Heinsen H; Amaro E; Grinberg LT; Krause B; Grothe M;
    Neurobiol Aging; 2014 Mar; 35(3):482-91. PubMed ID: 24176625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
    Teipel S; Grothe MJ;
    J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.
    Grothe M; Heinsen H; Teipel SJ
    Biol Psychiatry; 2012 May; 71(9):805-13. PubMed ID: 21816388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.
    Grothe MJ; Ewers M; Krause B; Heinsen H; Teipel SJ;
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S344-53. PubMed ID: 24418052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
    Teipel S; Grothe MJ;
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):526-36. PubMed ID: 26555082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment.
    Kilimann I; Hausner L; Fellgiebel A; Filippi M; Würdemann TJ; Heinsen H; Teipel SJ
    Cereb Cortex; 2017 Mar; 27(3):1841-1848. PubMed ID: 26879092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
    Cavedo E; Lista S; Houot M; Vergallo A; Grothe MJ; Teipel S; Zetterberg H; Blennow K; Habert MO; Potier MC; Dubois B; Hampel H; ; Alzheimer Precision Medicine Initiative
    Neurology; 2020 Jan; 94(1):e30-e41. PubMed ID: 31801830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
    Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
    J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.
    Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ
    J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
    Kljajevic V; Grothe MJ; Ewers M; Teipel S;
    Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
    Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
    J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease.
    Xia Y; Dore V; Fripp J; Bourgeat P; Laws SM; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe C; Masters CL; Coulson EJ; Maruff P
    Neurology; 2024 Jul; 103(2):e209626. PubMed ID: 38885444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease.
    Trzepacz PT; Hochstetler H; Yu P; Castelluccio P; Witte MM; Dell'Agnello G; Degenhardt EK;
    Dement Geriatr Cogn Disord; 2016; 41(1-2):68-79. PubMed ID: 26625159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.